Approval · Notice of Compliance 22136 · 2019
COMBOGESIC: Notice of Compliance 22136
Issued May 9, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22136
- Date
- May 9, 2019
- Company
- Aft Pharmaceuticals Ltd
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMBOGESIC | 02488280 | Marketed |
Medicinal ingredients
- ACETAMINOPHEN 325 MG per TAB
- IBUPROFEN 97.5 MG per TAB